Juul in Early Talks with Tobacco Companies for Sale or Partnership

Jan.27.2023

Juul in Early Talks with Tobacco Companies for Sale or Partnership

Juul explores possible sale, investment, licensing or distribution opportunities with Phillip Morris, Japan Tobacco, and Altria.

According to a January 26th report in the Wall Street Journal, vaping company JUUL is exploring potential opportunities for sale, strategic investment, licensing or distribution, and has recently held preliminary discussions with international companies Fima, Japan Tobacco and Altria Group.

According to sources familiar with the matter, negotiations are still in the early stages and there is no guarantee a sale or partnership agreement will be reached.

Reference:

The electronic cigarette company, Juul, is reportedly engaged in discussions with tobacco companies.

#Asia #Market #China #Disposable e-cigarettes #E-cigarette Companies

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Glas, the FDA, and the Future of Flavored ENDS

Glas, the FDA, and the Future of Flavored ENDS

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.

West Virginia Senate Backs Vape Tax Increase to Offset Income Tax Cut

West Virginia Senate Backs Vape Tax Increase to Offset Income Tax Cut

The West Virginia Senate approved a 10% personal income tax cut on February 22, 2026, with part of the revenue offset coming from increased excise taxes on vape and e-cigarette products.

New Zealand Vape Company Alt Becomes Government Partner After Suing Over Nicotine Limits

New Zealand Vape Company Alt Becomes Government Partner After Suing Over Nicotine Limits

Health NZ signed a NZD 500,000 contract with New Zealand-owned vape company Alt NZ Limited in December 2025 for its free vape kit programme for smokers, with more than 7,000 kits distributed so far.

Mar.23 by 2FIRSTS.ai

Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks

Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks

The Philippine Department of Health reiterated Saturday that vaping should not be promoted as an alternative to cigarette smoking, Health Secretary Teodoro “Ted” Herbosa said in a radio interview, according to the Tribune. Herbosa said both vaping and smoking pose irreversible health risks and cited E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI), claiming it led to the death of a 22-year-old male with no smoking history in 2025.

Feb.28 by 2FIRSTS.ai

Alaska AG warns 1,500+ retailers to stop selling unauthorized vapes and nicotine pouches

Alaska AG warns 1,500+ retailers to stop selling unauthorized vapes and nicotine pouches

Alaska’s attorney general has sent warning letters to more than 1,500 retailers and distributors, cautioning them against selling tobacco products — including e-cigarettes and oral nicotine pouches — that lack U.S. Food and Drug Administration authorization.

Mar.06 by 2FIRSTS.ai

Bonnie Herzog：U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands

Bonnie Herzog：U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands

Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.

Mar.04 by 2FIRSTS.ai

Related Topics

News

Related Read

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

West Virginia Senate Backs Vape Tax Increase to Offset Income Tax Cut

West Virginia Senate Backs Vape Tax Increase to Offset Income Tax Cut

New Zealand Vape Company Alt Becomes Government Partner After Suing Over Nicotine Limits

New Zealand Vape Company Alt Becomes Government Partner After Suing Over Nicotine Limits

Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks

Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks

Alaska AG warns 1,500+ retailers to stop selling unauthorized vapes and nicotine pouches

Alaska AG warns 1,500+ retailers to stop selling unauthorized vapes and nicotine pouches

Bonnie Herzog：U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands

Bonnie Herzog：U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands